Who are Anika Therapeutics, Inc.'s main suppliers?

Anika Therapeutics, Inc. (ANIK) key suppliers include: Johnson & Johnson. View the full supplier network at chainsifter.com/chain/ANIK.

Who are Anika Therapeutics, Inc.'s major customers?

Anika Therapeutics, Inc. (ANIK) key customers include: JOHNSON-JOHNSON-MEDTECH, Johnson & Johnson, Johnson & Johnson. View the full customer network at chainsifter.com/chain/ANIK.

What sector is Anika Therapeutics, Inc. in?

Anika Therapeutics, Inc. (ANIK) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Anika Therapeutics, Inc. (ANIK): 5 Verified Supply Chain Relationships

1Suppliers

3Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Anika Therapeutics, Inc. (ANIK) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

1Distinct source URLs

5High confidence

0.857Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Anika Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: ustomer, Johnson & Johnson MedTech (“J&J MedTech”) (previously known as DePuy Synthes Mitek Sports Medicine), a divisi…

Anika Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
JOHNSON-JOHNSON-MEDTECH	JOHNSON-JOHNSON-MEDTECH	92%	Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (‘J&J MedTech’), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 47…
JNJ	Johnson & Johnson	85%	l. The Company had no accrued warranties as of March 31, 2026, or December 31, 2025, and has no history of claims paid. 12 The Company is also involved from time-to-time in various legal proceedings …
JNJ	Johnson & Johnson	85%	Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: ustomer, Johnson & Johnson MedTech (“…

Anika Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ANIK-DEBT	Debt stack $26.6M	90%	Market cache reports total debt of $26.6M.

Anika Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Anika Therapeutics, Inc..

Anika Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
ANIK-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 129 tracked holders.

Anika Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SNNUF	Smith & Nephew plc	100.00	2
JNJ	Johnson & Johnson	100.00	1	['customer', 'supplier']
TKPHF	Takeda Pharmaceutical Company Limited	100.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
AVBP	ArriVent BioPharma, Inc.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
AORT	Artivion, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
FCX	Freeport-McMoRan Inc.	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
BNR	Burning Rock Biotech Limited	50.00	2
BNRG	Brenmiller Energy Ltd	50.00	2
AVTX	Avalo Therapeutics, Inc.	50.00	2
CSTE	Caesarstone Ltd.	50.00	2
CVRX	CVRx, Inc.	50.00	2
DYAI	Dyadic International, Inc.	50.00	2
ENGNW	enGene Therapeutics Inc.	50.00	2
ALC	Alcon Inc.	50.00	2
ATNM	Actinium Pharmaceuticals, Inc.	50.00	2
BLLN	BillionToOne, Inc.	50.00	2

Anika Therapeutics, Inc. Supply Chain